51 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Portola Pharmaceuticals, Inc. PTLA shares climbed 129% to $17.76 after the company announced it will be acquired by Alexion Pharmaceuticals, Inc. ALXN for $18 per share in cash.
• CleanSpark, Inc. CLSK climbed 73.5% to $2.3602 after the company reported a strong rise in year-to-date revenue through April 2020.
• Genprex, Inc. GNPX gained 67.5% to $3.87 after the company reported exclusive global patent and technology license deal for combo of its TUSC2 gene therapy with Immunotherapies.
• MicroVision, Inc MVIS shares climbed 52.7% to $1.68 after jumping 148% on Monday. MicroVision is expected to release Q1 results on May 7.
• TETRA Technologies, Inc. TTI shares gained 41.3% to $0.5834 after the company reported better-than-expected Q1 results.
• Adverum Biotechnologies, Inc. ADVM gained 36.1% to $18.69 after the company announced new interim clinical data from Cohorts 1-3 of the OPTIC Phase 1 dose-ranging clinical study of single-dose of ADVM-022 intravitreal injection gene therapy in patients with wet age-related macular degeneration, which further demonstrated the transformative potential of ADVM-022 to greatly reduce anti-VEGF injection burden in wet AMD. SunTrust Robinson Humphrey upgraded the stock from Hold to Buy and announced a price target of $21 per share.
• Akebia Therapeutics, Inc. AKBA shares climbed 35.9% to $11.77 after the company announced the results from its Phase 3 program of Vadadustat for treatment of Anemia achieved primary efficacy and cardiovascular safety endpoints. The company reported upbeat Q1 results.
• Chegg, Inc. CHGG rose 33.9% to $58.63 after the company reported better-than-expected Q1 results and issued Q2 sales guidance above estimates. The company’s quarterly service subscribers rose 35% year over year. Raymond James upgraded Chegg from Market Perform to Outperform.
• TG Therapeutics, Inc. TGTX surged 25.6% to $15.65 after the company announced the results from its UNITY-CLL Phase 3 study for patients with Chronic Lymphocytic Leukemia met its primary endpoint.
• Wayfair Inc. W gained 25.1% to $167.81 after the company reported narrower-than-expected Q1 loss.
• EverQuote, Inc. EVER surged 25% to $49.72 following better-than-expected Q1 results.
• Textainer Group Holdings Limited TGH gained 20.8% to $9.51.
• CohBar, Inc. CWBR surged 20% to $4.02.
• Acadia Healthcare Company, Inc. ACHC rose 19.2% to $25.72 following upbeat Q1 earnings.
• Addus HomeCare Corporation ADUS gained 19% to $87.94.
• Marlin Business Services Corp. MRLN surged 18.8% to $9.83.
• Iteris, Inc. ITI gained 18.4% to $4.50 after the company agreed to sell agriculture and weather analytics segment to DTN for $12 million in cash. Iteris expects Q4 and full year revenue to increase approximately 21% and 16%.
• Super League Gaming, Inc. SLGG climbed 18% to $2.8457. Super League Gaming saw a 259% growth in monthly visitors to Minehut between December and April.
• ObsEva SA OBSV gained 17.4% to $2.83 after reporting Q1 results.
• IPG Photonics Corporation IPGP climbed 17.3% to $139.67 following strong Q1 results.
• ArcBest Corporation ARCB rose 17.2% to $22.56.
• Diebold Nixdorf, Incorporated DBD gained 17.1% to $5.15 following Q1 results.
• SG Blocks, Inc. SGBX shares rose 15.7% to $5.01 after the company signed an agreement with OSANG Healthcare to distribute coronavirus rapid tests in the US under OSANG's FDA emergency use authorization.
• Veru Inc. VERU gained 14.2% to $3.8350 after reporting results from VERU-111 Phase 1b/2 trial in men with metastatic castration-resistant prostate cancer.
• Cutera, Inc. CUTR climbed 13.4% to $14.65.
• Aptinyx Inc. APTX surged 13.1% to $3.29.
• Tiziana Life Sciences PLC TLSA rose 12.9% to $3.33.
• Welbilt, Inc. WBT gained 11.6% to $5.31 following Q1 earnings.
• Chembio Diagnostics, Inc. CEMI rose 11.4% to $13.65 after the company reported Q1 results and attained CE marking for DPP coronavirus COVID-19 system for IgG and IgM antibodies.
• New Residential Investment Corp. NRZ gained 11.1% to $6.73 after the company reported its Q1 earnings results.

Check out these big penny stock gainers and losers

Losers

• Norwegian Cruise Line Holdings Ltd. NCLH shares dipped 20% to $11.55 after the company reported a $350 million common stock offering. Norwegian Cruise's NCL Corp. reported a $400 million investment by L Catteron.
• Fulgent Genetics, Inc. FLGT fell 19.4% to $13.28 following downbeat Q1 earnings.
• Itron, Inc. ITRI fell 18.2% to $55.10 after the company reported weaker-than-expected Q1 sales. The company also suspended FY20 guidance.
• Capitala Finance Corp. CPTA dipped 17.4% to $3.105 after reporting downbeat Q1 sales.
• Hertz Global Holdings, Inc. HTZ fell 16.1% to $3.0121 as multiple reports suggested the company is nearing a bankruptcy filing. The car rental company has hired an additional advisor to help prepare for a planned bankruptcy filing, according to The Wall Street Journal.
• Oxford Immunotec Global PLC OXFD dropped 15% to $10.00 following weak quarterly earnings.
• Midatech Pharma plc MTP fell 13.6% to $3.4395.
• WestRock Company WRK dropped 13.4% to $26.24 after the company reported Q2 results.
• Antares Pharma, Inc. ATRS dipped 13.5% to $2.845 after the company reported Q1 results.
• Phunware, Inc. PHUN fell 12.2% to $0.7110 after jumping 20% on Monday. Phunware launched a mobile healthcare solution for integrated health system in New York.
• Compass Diversified Holdings LLC CODI fell 12% to $16.66. Compass Diversified priced its 5 million share offering at $17.60 per share.
• Ardmore Shipping Corporation ASC fell 12% to $6.01 after reporting Q1 results.
• Mallinckrodt plc MNK dropped 11.5% to $2.9219 following weak Q1 sales.
• Capricor Therapeutics, Inc. CAPR fell 11.1% to $6.48.
• LMP Automotive Holdings, Inc. LMPX fell 10.9% to $4.6767.
• Berkshire Hills Bancorp, Inc. BHLB dropped 10% to $14.01 after reporting Q1 results.
• Bloomin' Brands, Inc. BLMN fell 9.9% to $9.39 after the company reported preliminary Q1 results and announced a proposed private offering of convertible senior notes due 2025.
• Centennial Resource Development, Inc. CDEV fell 9% to $0.9379 after the company reported worse-than-expected Q1 sales.
• IZEA Worldwide, Inc. IZEA shares fell 8.3% to $0.3478 after jumping more than 73% on Monday.
• KemPharm, Inc. KMPH fell 8.2% to $0.2693 after declining around 7% on Monday.
• Medigus Ltd. MDGS fell 8.1% to $3.0510 after dropping over 6% on Monday.